Filing Flows › Consumer Staples › Stepan (SCL)
Stepan (SCL) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · Stepan (SCL) Q3 2026 earnings results →
Q3 2026 Revenue up 17% year over year to $692M · 3¢ of every $1 of revenue kept as net profit · operating margin 3.8%
Stepan made $692M in Q3 2026 (+17% Y/Y): Surfactants $487M, Polymers $179M, Specialty Products $26.9M. Operating margin 3.8%, net earnings $17.8M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $692.2M in Q3 2026, up 17% year over year and up 1% from the previous quarter. Surfactants was the largest line at 70% of revenue. Surfactants added $64.3M year over year (up 15%), 63% of the total change.
Gross margin was 12.7%, up 0.6 points from Q3 2025. Operating profit was $26.0M, a 3.8% margin (up 0.1 points year over year). Of the extra revenue versus Q3 2025, 4% reached operating profit, above the 4% margin then. Operating expenses grew 25% against revenue growth of 17%. The fastest-growing cost line was Other operating costs (+41%). Net earnings were $17.8M, up 64% year over year. The effective tax rate was 10.2%.
Operating cash flow was $29.3M (down 58% year over year), 165% of net earnings. Non-cash charges added back $31.3M of depreciation and amortization and $2.2M of share-based compensation. Working capital and other items used $21.9M. Capital expenditures of $21.2M left free cash flow of $8.2M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 4, 2026 | $692M | +17% | 3.8% | $17.8M | $29.3M |
| Q2 2026 | 10-Q | Aug 5, 2026 | $684M | +15% | 5.4% | $22.9M | $8.4M |
| Q1 2026 | 10-Q | May 6, 2026 | $605M | +2% | -8.2% | −$41.4M | $16.9M |
| Q4 2025 | 10-K | Feb 26, 2026 | $554M | +5% | 1.9% | $5.0M | $60.0M |
| Q3 2025 | 10-Q | Nov 5, 2025 | $590M | +8% | 3.7% | $10.8M | $69.8M |
| Q2 2025 | 10-Q | Aug 6, 2025 | $595M | +7% | 3.0% | $11.3M | $11.2M |
| Q1 2025 | 10-Q | May 7, 2025 | $593M | +8% | 4.8% | $19.7M | $6.9M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Stepan against its Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +17% against the peers' median +13%. Operating margin: 3.8% against the peers' median 17.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| SCL Stepan | Q3 2026 | $692M | +17% | 3.8% |
| PG Procter & Gamble | Q1 FY27 | $23.3B | +4% | 25.5% |
| ECL Ecolab | Q3 2026 | $4.7B | +13% | 17.3% |
| CHD Church & Dwight | Q3 2026 | $1.6B | +1% | 18.2% |
| XAGE Longevity Health Holdings | Q2 2026 | $396K | -21% | -182.9% |
| ORIB Orion Bliss | Q1 FY27 | $12K | +300% | -32.0% |
Source: Stepan 10-Q on SEC EDGAR · CIK 94049 · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Guidance and outlook
13F: who owns SCL and who is buying
More on SCL
- How Stepan makes money: revenue by segment
- Stepan next earnings date and what analysts expect
- Stepan stock forecast, price target and fair value
- Who owns Stepan stock: holders, funds and Congress trades
- Stepan guidance and outlook
- Is Stepan a takeover target? LBO and rumors
- Stepan recalls, complaints and regulation
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results
- Stepan guidance history: guided vs reported
- Stepan gross margin by quarter
- Stepan operating margin by quarter
- Stepan net income by quarter
- Stepan free cash flow by quarter
- Stepan capital expenditures by quarter
- Stepan Surfactants revenue by quarter
- Stepan Polymers revenue by quarter
- Stepan Specialty Products revenue by quarter